Global Market for Women’s Health Therapeutics Expected to Reach $22.5 Billion in 2018; Postmenopausal Osteoporosis Claims 53% Market Share
May 29, 2014
Wellesley, Mass., May 29, 2014 – BCC Research(www.bccresearch.com) reveals in its new report,Therapeutics for Women's Health: Technologies and Global Markets, the global market for women’s health therapeutics is expected to grow to $22.5 billion by 2018, with a five-year compound annual growth rate (CAGR) of 3.5%. The postmenopausal osteoporosis therapeutics segment leads the global market, claiming 53% market share.
Women’s health issues have gained significant market attention recently as a result of disease pattern and treatment differences between men and women. The U.S. segment, by far the largest- and fastest-growing regional market, is expected to reach $13.5 billion by 2018, registering a CAGR of 4.7%.
The European and Japanese markets are projected to approach $7.5 billion and nearly $1.4 billion, respectively, by 2018, at CAGRs of 1.7% and 1.8%.
Currently, postmenopausal osteoporosis dominates the global market for women’s health therapeutics and technologies, followed by menopause, endometriosis, and polycystic ovary syndrome, which claim 30%, 14%, and 4% of the total market, respectively.
“Patent expiry is one of the key challenges for the growth of this market and has resulted in a slowdown in recent few years due to patent expiries of blockbusters such as Evista, the Premarin family, Actonel, and other drugs,” says BCC Research biotechnology analyst Dr. Ritu Thakur Dangi. “However, the launch of novel therapies (e.g., elagolix, odanacatib, Femitra, among others) in the late-stage pipeline has the strong potential to drive the market during the forecast period.”
Therapeutics for Women's Health: Technologies and Global Marketsprovides an overview of the global market for women’s health therapeutics. It includes analyses of global market trends, with data from 2012 and 2013, and projections of CAGRs through 2018.


Editors and reporters who wish to speak with the analyst, should contact Steven Cumming at steven.cumming@bccresearch.com.
Therapeutics for Women's Health: Technologies and Global Markets( BIO043E )
Publish Date: May 2014
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Cell Biology
- BCC Research Presents 2024 Diagnostics Research Review: Market Growth and Innovations
- CAR T-Cell Therapy Market to Surge at 40.2% CAGR Over the Next Five Years
- BCC Research Releases 2024 Protein Synthesis Research Review
- Global Industrial Enzyme Markets: Innovation, Impact, and Growth
- DNA and RNA Sequencing Markets Set for Rapid Expansion, Says BCC Research
Reports from Cell Biology
Recent News
- Global Market for Emerging Medical Device Technologies to Hit $223.9 Billion by 2029
- Emerging Clinical Trial Infrastructure in the MENA Region: A Comprehensive Market Analysis
- Cancer Therapeutics Market Forecast to Reach $168 Billion by 2029, Highlighting Recurrent and Metastatic Innovations
- Global Cancer Immunotherapy Market Projected to Reach $247 Billion by 2029, Driven by 11.4% CAGR
- Liver Disease Treatments: Global Market Forecast and Emerging Trends Through 2030